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ABSTRACT 
 
The first investigation of the chemical constituents and bioactivities of Diospyros rubra Lec. 
is reported. D. rubra extracts were screened for antimicrobial, antimalarial and cytotoxic ac-
tivities. They were only shown to be active antimalarials. The extracts with good antimalarial 
activity were isolated and extensively purified to give lupeol (1), lupenone (2), betulin (3), 
lupeol acetate (4), 28-O-acetylbetulin (5), β-sitosteryl-3-O-β-D-glucopyranoside (6) and a 
mixture of β-sitosterol and stigmasterol. Some of the isolates were tested for antimicrobial 
and cytotoxic actions. Betulin (3) displayed antimicrobial activity against Streptococcus pyo-
genes with a minimum inhibitory concentration (MIC) of 85 µg/mL. Interestingly, bioactive 
fractions all selectively exerted some antimicrobial activity against Corynebacterium diphthe-
riae NCTC 10356 with the MIC range of 64–256 µg/mL. The study provides data to support 
the medicinal importance of the D. rubra. 
 
Keywords: Diospyros rubra Lec.; triterpenoids; antimicrobial; antimalarial and cytotoxic 
activities 
 
 
INTRODUCTION 
 
Previously, many species of Diospyros 
were studied and a diverse group of com-
pounds such as triterpenoids, steroids, naph-
thaquinones, hydrocarbons and lipids were 
found (Jain et al., 1994; Kuo et al., 1997). 
However, no chemical and pharmacological 
studies of Diospyros rubra Lec. (Ebenaceae) 
have been reported in the literature to date. 
D. rubra is a medicinal plant known in Thai 
as “Phaya-raak-dam”. It has been used as an 
indigenous medicine for treatment of pain 
and tuberculosis (Bunyapraphatsara and 
Chokechareunporn, 1999). In continuation 
of our investigations of medicinal plants, the 
components of D. rubra were isolated and 
tested for antimicrobial, antimalarial and 
cytotoxic activities. The present study re-
ports some bioactive triterpenes from this 
plant species. 
 
MATERIALS AND METHODS 
 
General 
Melting points were determined on an 
Electrothermal 9100 melting point apparatus 
and were uncorrected. 1H- and 13C-NMR 
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spectra were recorded on a Bruker 
AVANCE 300 NMR spectrometer (opera-
ting at 300 MHz for 1H and 75 MHz for 
13C). Infrared spectra (IR) were obtained on 
a Perkin Elmer System 2000 FTIR. Mass 
spectra were recorded on a Finnigan INCOS 
50. Column chromatography was carried out 
using silica gel 60 (0.063–0.200 mm). Ana-
lytical thin layer chromatography (TLC) 
was performed on silica gel 60 PF254 alu-
minium sheets (cat. No. 7747 E., Merck). 
Solvents were distilled prior to use. Chemi-
cals for cell culture and assays were RPMI-
1640 (Gibco and Hyclone laboratories, 
USA), HEPES, L-glutamine, penicillin, 
streptomycin, sodium pyruvate and glucose 
(Sigma, USA), Ham’s/F12, fetal bovine se-
rum (FBS, Hyclone laboratories, USA), gen-
tamicin sulfate (Government Pharmaceutical 
Organization, Thailand), 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT, Sigma-Aldrich, USA). 
 
Plant materials 
Stems of D. rubra were collected from 
Thap Sakae, Prachuap Khiri Khan Province, 
Thailand. It has been identified (BKF 
151270) by The Forest Herbarium, Royal 
Forestry Department, Bangkok. A voucher 
specimen has been deposited at Department 
of Chemistry, Faculty of Science, Srina-
kharinwirot University, Bangkok, Thailand. 
 
Extraction 
The milled air dried D. rubra (7 kg) was 
extracted with hexane 10 L (3 × 5 days), fol-
lowed by filtration. The filtrates were com-
bined and evaporated in vacuo to give a 
hexane extract (22 g). Similar extraction 
was conducted using dichloromethane, ethyl 
acetate and methanol to give dichloro-
methane (17 g), ethyl acetate (16 g) and 
methanol (95 g) extracts, respectively. 
 
Isolation 
The extracts were isolated by silica gel 
column chromatography using gradient elu-
tion with solvent mixtures of increasing po-
larity. Fractions were combined based on 
TLC and evaporated to dryness in vacuo. 
The dichloromethane extract (17 g) was 
subjected to a silica gel (800 g) column 
chromatography, then eluted by hexane-
dichloromethane and dichloromethane-ethyl 
acetate to give five fractions: D1-D5. Three 
selected fractions D2, D3 and D4 were rese-
parated. D2 (1.0 g of yellow oily liquid from 
7:3 hexane-CH2Cl2) was placed onto a silica 
gel (40 g) column. Elution with hexane-
CH2Cl2 gave four fractions D2.1–D2.4; 
D2.2, a red oil, gave lupenone (2; 12.2 mg 
as oily liquid) from 85:15 hexane-CH2Cl2 
elution.  
D2.3 was obtained as pale violet solid 
(from 1:9 hexane-CH2Cl2 elution) of lupeol 
(1; 25.8 mg); mp 220–222 °C (lit. mp 221–
223 °C, Yoshihira et al., 1971). 
Fraction D3 (1.5 g of brown solid eluted 
with 2:8 hexane-CH2Cl2) was recrystallized 
from hexane to give additional compound 1 
(800.6 mg).  
Fraction D4, a yellow solid (5.3 g) ob-
tained by elution with 9:1 CH2Cl2-EtOAc 
was rechromatographed on a silica gel (200 
g) column to provide five fractions D4.1–
D4.5. Fraction D4.1 (0.1 g of green solid 
from 7:3 hexane-CH2Cl2 elution) was re-
crystallized from hexane to give lupeol (1; 
74.3 mg). D4.2 (0.2 g of red brown solid 
eluted with 1:9 hexane-CH2Cl2) was placed 
onto a silica gel (8 g) column and elution 
with 3:7 hexane-CH2Cl2 gave fraction 
D4.2.1 (light green solid 49.8 mg) which 
was recrystallized from methanol to afford a 
mixture of β-sitosterol and stigmasterol 
(40.2 mg). Fraction D4.3 (2.5 g of yellow 
solid from 1:9 hexane-CH2Cl2 elution) was 
applied to a silica gel (100 g) column and 
eluted with 3:7 hexane-CH2Cl2 to give frac-
tion D4.3.1, a mixture of β-sitosterol and 
stigmasterol (3.3 mg). Next, elution with 2:8 
hexane-CH2Cl2 gave fraction D4.3.2, a pale 
yellow solid (57.2 mg) of long chain hydro-
carbon which was not identified. Further 
elution with CH2Cl2 provided fraction 
D4.3.3; a yellow–green solid (140 mg) 
which was rechromatographed on a silica 
gel (6 g) column. Elution with CH2Cl2 af-
forded fraction D4.3.3.1 of a green solid 
(34.4 mg), followed by 95:5 CH2Cl2-EtOAc 
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elution to give fraction D4.3.3.2 as a yellow 
solid (50.6 mg). Recrystallization of D4.3.3.2 
from methanol provided a white solid of 
betulin (3); 39.1 mg; mp 237–240 °C (lit mp 
236–238 °C, Tinto et al., 1992).  
The ethyl acetate extract (16 g) was 
separated as described on a silica gel (800 g) 
column to provide seven fractions E1–E7. 
Fractions E1-E4 and E6-E7 were reisolated. 
E1 (0.4 g of light green solid from 1:1 hex-
ane-CH2Cl2 elution) was rechromatographed 
on a silica gel (8 g) to give fraction E1.1 (10 
mg of oily liquid from 9:1 hexane- CH2Cl2). 
Further elution with 8:2 hexane-CH2Cl2 
gave fraction E1.2 (81.7 mg of yellow solid) 
which after recrystallization from MeOH 
afforded lupeol acetate (4; 50.9 mg; mp 
190–192 °C).  
Elution with 4:6 hexane-CH2Cl2 gave 
yellow solids of E2 (0.1 g) and E3 (1.4 g) 
which were recrystallized from MeOH to 
give 60.4 and 73.5 mg of lupeol (1), respec-
tively. Fraction E4 (1.1 g of oily brown liq-
uid from 9:1 CH2Cl2-EtOAc elution) was 
placed onto a silica gel (35 g) and eluted 
with CH2Cl2, CH2Cl2-EtOAc and EtOAc- 
MeOH to give four subfractions E4.1–E4.4. 
E4.1 was a pale yellow solid (7.8 mg). E4.2 
(15.0 mg as light-brown solid from CH2Cl2 
elution) was recrystallized from MeOH to 
give a mixture of β-sitosterol and stigma-
sterol. E4.3, a yellow solid (169.7 mg from 
95:5 CH2Cl2-EtOAc elution) was recrystal-
lized from MeOH to afford a white solid of 
28-O-acetylbetulin (5; 81.4 mg; mp 209–
210 °C). Fraction E4.4 (360 mg of oily 
brown liquid from 1:1 EtOAc-MeOH elu-
tion) was rechromatographed on a silica gel 
(15 g) to provide a green solid (51.6 mg 
from hexane-CH2Cl2, 4:6) which was re-
crystallized from MeOH to give white solid 
(14.6 mg) of long chain hydrocarbon. Frac-
tion E6 (1.5 g of brown solid from 85:15 
CH2Cl2-EtOAc elution) was placed onto sil-
ica gel (50 g) to give five fractions E6.1–
E6.5; E6.2 (28.8 mg of pale yellow solid 
from 9:1 CH2Cl2-EtOAc elution) was re-
crystallized from MeOH to provide white 
solid of long chain hydrocarbon (9.1 mg). 
E6.3, as yellow solid (101.9 mg from 95:5 
CH2Cl2-EtOAc) was recrystallized from 
MeOH to give betulin (3; 22.6 mg). Fraction 
E7 (2.1 g of brown solid from 1:1 CH2Cl2-
EtOAc) was recrystallized from MeOH to 
afford β-sitosteryl-3-O-β-D-glucopyrano-
side (6; 5.1 mg); mp 285–287 °C (lit. mp 
286 °C, Mitra and Misra, 1965). 
 
Spectral data 
Lupeol (1); IR (CHCl3): υmax 3,345, 2,944, 
2,862, 1,638, 1,453, 1,380, 1,043 cm−1; 1H-
NMR (CDCl3): δ 0.66 (d, 1H, J = 9.1 Hz, H-
5), 0.73 (s, 3H, H-24), 0.76 (s, 3H, H-28), 
0.80 (s, 3H, H-25), 0.92 (s, 3H, H-27), 0.94 
(s, 3H, H-23), 1.00 (s, 3H, H-26), 1.65 (s, 
3H, H-30), 1.82–1.96 (m, H-21), 2.35 (dt, 
1H, J = 10.9, 5.5 Hz, H-19), 3.16 (dd, 1H, J 
= 10.8, 5.1 Hz, H-3), 4.55 (br s, 1H, H-29), 
4.65 (br s, 1H, H-29); 13C-NMR (CDCl3): δ 
14.5 (C-27), 15.3 (C-24), 15.9 (C-25), 16.1 
(C-26), 18.0 (C-28), 18.3 (C-6), 19.3 (C-30), 
20.9 (C-11), 25.1 (C-12), 27.4 (C-2, C-15), 
28.0 (C-23), 29.7 (C-21), 34.3 (C-7), 35.6 
(C-16), 37.1 (C-10), 38.0 (C-13), 38.7 (C-1), 
38.8 (C-4), 40.0 (C-22), 40.8 (C-8), 42.8 (C-
14), 43.0 (C-17), 48.0 (C-18), 48.3 (C-19), 
50.4 (C-9), 55.3 (C-5), 79.0 (C-3), 109.3 (C-
29), 150.9 (C-20); LRMS (EI): m/z (%) = 
426 (34)[M]+, 411 (30), 218 (23), 189 (34), 
91 (100), 77 (65). 
 
Lupenone (2); IR (CHCl3): υmax 2,927, 
2,860, 1,708, 1,459, 1,382 cm−1; 1H-NMR 
(CDCl3): δ 0.77 (s, 3H, H-28), 0.90 (s, 3H, 
H-25), 0.93 (s, 3H, H-27), 1.00 (s, 3H, H-
24), 1.04 (s, 3H, H-23), 1.22 (s, 3H, H-26), 
1.66 (s, 3H, H-30), 1.84-1.97 (m, H-21), 
2.24-2.52 (m, H-19), 4.55 (br s, 1H, H-29), 
4.66 (br s, 1H, H-29); 13C-NMR (CDCl3): δ 
14.4 (C-27), 15.7 (C-26), 15.9 (C-25), 17.9 
(C-28), 19.2 (C-6), 19.6 (C-30), 21.0 (C-24), 
21.4 (C-11), 25.1 (C-12), 26.6 (C-23), 27.4 
(C-15), 29.6 (C-21), 33.5 (C-7), 34.1 (C-2), 
35.5 (C-16), 36.8 (C-10), 38.1 (C-13), 39.6 
(C-1), 39.39 (C-22), 40.7 (C-8), 42.8 (C-14), 
42.9 (C-17), 47.3 (C-4), 47.9 (C-19), 48.2 
(C-18), 49.7 (C-9), 54.9 (C-5), 109.3 (C-29), 
150.8 (C-20), 218.2 (C-3); LRMS (EI): m/z 
(%) = 424(10) [M]+, 218 (7), 189 (13), 91 
(100), 77 (66). 
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Betulin (3); IR (CHCl3): υmax 3,396, 2,941, 
2,862, 1,643, 1,545, 1,375, 1,027 cm−1; 1H-
NMR (CDCl3): δ 0.65 (d, 1H, J = 9.4 Hz, H-
5), 0.73 (s, 3H, H-24), 0.79 (s, 3H, H-25), 
0.94 (s, 3H, H-27), 0.95 (s, 3H, H-23), 0.99 
(s, 3H, H-26), 1.65 (s, 3H, H-30), 2.35 (dt, 
1H, J = 10.5, 6.2 Hz, H-19), 3.16 (dd, 1H, J 
= 10.8, 4.9 Hz, H-3), 3.30 (d, 1H, J = 10.8, 
H-28), 3.77 (d, 1H, J = 10.8 Hz, H-28), 4.55 
(br s, 1H, H-29), 4.65 (br s, 1H, H-29); 13C-
NMR (CDCl3) : δ 14.7 (C-27), 15.3 (C-24), 
15.9 (C-26), 16.0 ( C-25), 18.2 (C-6), 19.0 
(C-30), 20.8 (C-11), 25.2 (C-12), 27.0 (C-
15), 27.3 (C-2), 27.9 (C-23), 29.1 (C-16), 
29.7 (C-21), 33.9 (C-22), 34.2 (C-7), 37.1 
(C-13), 37.3 (C-10), 38.6 (C-1), 39.3 (C-4), 
40.9 (C-8), 42.7 (C-14), 47.7 (C-17, C-18), 
48.7 (C-19), 50.3 (C-9), 55.2 (C-5), 60.5 (C-
28), 78.9 (C-3), 109.6 (C-29), 150.4 (C-20); 
LRMS (EI): m/z (%) = 442 (18)[M]+, 411 
(63), 203 (48), 189 (21), 91 (79), 77 (100). 
 
Lupeol acetate (4): IR (CHCl3): υmax 2,942, 
2,866, 1,735, 1,451, 1,379, 1,243, 1,027 
cm−1; 1H-NMR (CDCl3): δ 0.76 (dd, 1H, J = 
10.8, 5.8 Hz, H-5), 0.81 (s, 3H, H-28), 0.82 
(s, 9H, H-23, H-24, H-25), 0.91 (s, 3H, H-
27), 1.00 (s, 3H, H-26), 1.66 (s, 3H, H-30), 
1.82-1.93 (m, 2H, H-21), 2.01 (s, 3H, H-2′), 
2.33 (dt, 1H, J = 11.1, 5.6 Hz, H-19), 4.44 
(dd, 1H, J = 10.8, 5.8 Hz, H-3), 4.54 (br s, 
1H, H-29), 4.66 (br s, 1H, H-29); 13C-NMR 
(CDCl3): δ 14.5 (C-27), 15.9 (C-24), 16.1 
(C-25), 16.4 (C-26), 17.9 (C-28), 18.1 (C-6), 
19.0 (C-30), 21.3 (C-2′), 20.9 (C-11), 23.7 
(C-2), 25.0 (C-12), 27.4 (C-15), 28.2 (C-23), 
29.8 (C-21), 34.2 (C-7), 35.5 (C-16), 37.0 
(C-10), 37.7 (C-4), 38.0 (C-13), 38.3 (C-1), 
39.9 (C-22), 40.8 (C-8), 42.8 (C-14), 42.9 
(C-17), 48.0 (C-18), 48.2 (C-19), 50.3 (C-9), 
55.3 (C-5), 80.9 (C-3), 109.3 (C-29), 150.9 
(C-20), 171.0 (C-1′); LRMS (EI): m/z (%) = 
468 (28)[M]+, 396 (100), 218 (24), 189 (22), 
91 (49). 
 
28-O-Acetylbetulin (5); IR (CHCl3): υmax 
3,587, 2,942, 2,868, 1,739, 1,458, 1,388, 
1,239, 1,033; 1H-NMR (CDCl3): δ 0.65 (d, 
1H, J = 9.0, H-5), 2.04 (s, 3H, H-2′′), 1.00 
(s, 3H, H-24), 0.73 (s, 3H, H-25), 0.94 (s, 
3H, H-23), 0.95 (s, 3H, H-27), 0.80 (s, 3H, 
H-26), 1.65 (s, 3H, H-30), 2.42 (dt, 1H, J = 
10.8, 5.8 Hz, H-19), 3.16 (dd, 1H, J = 10.3, 
4.8 Hz, H-3), 3.83 (d, 1H, J = 11.0 Hz, H-
28), 4.22 (d, 1H, J = 11.0 Hz, H-28), 4.56 
(br s, 1H, H-29), 4.66 (br s, 1H, H-29); 13C-
NMR (CDCl3): δ 14.7 (C-27), 15.3 (C-24), 
16.0 (C-25, C-26), 18.2 (C-6), 19.1 (C-30), 
20.7 (C-11), 21.0 (C-2′′), 25.1 (C-12), 27.0 
(C-15), 27.3 (C-2), 27.9 (C-23), 29.5 (C-16), 
29.7 (C-21), 34.1 (C-22), 34.5 (C-7), 37.5 
(C-13), 38.7 (C-1, C-10), 38.8 (C-4), 40.8 
(C-8), 42.6 (C-14), 46.3 (C-17), 47.6 (C-18), 
48.7 (C-19), 50.3 (C-9), 55.2 (C-5), 62.8 (C-
28), 78.9 (C-3), 109.8 (C-29), 150.1 (C-20), 
171.6 (C-1′′); LRMS (EI): m/z (%) = 484 
(36)[M]+ , 466 (84), 411 (63), 216 (52), 189 
(84), 91 (100). 
 
β-Sitosteryl-3-O-β-D-glucopyranoside (6): 
IR (CHCl3): υmax 3,385, 2,938, 1,458, 1,436, 
1,030; 1H-NMR (CDCl3): δ 0.61-0.94 (m, 
6CH3), 1.18-2.30 (m, CH, CH2), 4.34 (d, H, 
J = 7.5 Hz, H-1′); 3.22 (m, H-3), 3.22-3.76 
(glycosidic H), 5.29 (br s, 1H, H-6); 13C-
NMR (CDCl3): δ 11.7 (C-18), 11.8 (C-29), 
18.7 (C-26), 18.9 (C-19), 19.2 (C-27), 19.7 
(C-21), 20.9 (C-11), 22.9 (C-15), 24.2 (C-
28), 25.9 (C-23), 28.1 (C-16), 29.0 (C-25), 
29.5 (C-2), 31.8 (C-7), 33.8 (C-22), 36.0 (C-
8), 36.5 (C-10), 37.1 (C-1), 39.6 (C-20), 
42.2 (C-12), 45.7 (C-4, C-13), 49.9 (C-9), 
55.9 (C-17, C-24), 56.6 (C-14), 61.9 (C-6′), 
70.0 (C-3, C-4′), 76.2 (C-5′), 73.4 (C-2′), 
75.5 (C-3′), 101.0 (C-1′), 122.2 (C-6), 140.1 
(C-5). 
 
Cell cultures 
Chloroquine Resistant Plasmodium falcipa-
rum (T9.94) 
Human erythrocytes (type O) infected 
with chloroquine resistant P. falciparum 
(T9.94) were maintained in continuous cul-
ture, according to the method described pre-
viously (Satayavivad et al., 2004). RPMI-
1640 culture medium supplemented with 25 
mM of HEPES, 40 mg/L gentamicin sulfate 
and 10 mL of human serum was used in 
continuous culture. 
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Cancer cells 
Cancer cell lines were human cholangio-
carcinoma cancer cells (HuCCA-1) and hu-
man epidermoid carcinoma of the mouth 
(KB). The cells were grown in Ham’s/F12 
medium containing 2 mM L-glutamine sup-
plemented with 100 U/mL penicillin, strep-
tomycin and 10 % fetal bovine serum. 
 
Antimicrobial assay 
The antimicrobial activity of the tested 
compounds was carried out using the agar 
dilution method (Prachayasittikul et al., 
2008a). Briefly, the tested compounds dis-
solved in DMSO were individually mixed 
with Müller Hinton (MH) broth (1 mL) 
while the negative control was the MH broth 
plus DMSO without the tested compounds. 
The solution was then transferred to the MH 
agar solution to yield the final concentra-
tions of 32–256 µg/mL. Twenty seven 
strains of microorganisms, cultured in MH 
broth at 37 °C for 24 h, were diluted with 
0.9 % normal saline solution to adjust the 
cell density of 3 × 109 cell/mL. The organ-
isms were inoculated onto each plate and 
further incubated at 37 °C for 18–48 h. 
Compounds which showed high efficacy to 
inhibit bacterial cell growth were identified. 
The tested microorganisms were gram 
negative bacteria: Escherichia coli ATCC 
25922, Klebsiella pneumoniae ATCC 
700603, Salmonella typhimurium ATCC 
13311, Salmonella choleraesuis ATCC 
10708, Pseudomonas aeruginosa ATCC 
15442, Edwardsiella tarda, Shigella 
dysenteriae, Citrobacter freundii, Morgan-
ella morganii, Vibrio cholera, Vibrio 
mimicus, Aeromonas hydrophila, Plesiomo-
nas shigelloides, Xanthomonas maltophilia, 
Neisseria mucosa, Branhamella catarrhalis; 
gram positive bacteria: Staphylococcus 
aureus ATCC 25923, Staphylococcus epi-
dermidis ATCC 12228, Enterococcus fae-
calis ATCC 29212, Micrococcus lutens 
ATCC 10240, Corynebacterium diphtheriae 
NCTC 10356, Bacillus subtilis ATCC 6633, 
Streptococcus pyogenes, Listeria monocyto-
genes, Bacillus cereus, Micrococcus flavas 
and a diploid fungus (yeast): Candida albi-
cans.  
 
Antimalarial assay 
Antimalarial activity of the tested com-
pounds was evaluated against chloroquine 
resistant P. falciparum (T9.94) using the 
literature method (Trager and Jensen, 1976). 
Before performing the experiment, P. falci-
parum culture was synchronized by using 
sorbitol induced hemolysis according to the 
method of Lambros and Vanderberg 
(Lambros and Vanderberg, 1979) to obtain 
only ring stage-infected red blood cells and 
then incubated for 48 h prior to the drug 
testing to avoid the influence of sorbitol. 
The experiments were started with synchro-
nized suspension of 0.5 % to 1 % infected 
red blood cell during ring stage. Parasites 
were suspended with culture medium sup-
plemented with 15 % human serum to ob-
tain 10 % cell suspension. The parasite 
suspension was put into 96-well micro-
culture plate; 50 µL in each well and then 50 
µL of various tested drug concentrations 
were added. These parasite suspensions 
were incubated for 48 h in the atmosphere of 
5 % CO2 at 37 °C. The percents parasitemia 
of control and tested compounds were 
examined by microscopic technique using 
methanol-fixed Giemsa stained of thin 
smear blood preparation. The bioactivity of 
the compounds was evaluated by deter-
mining the concentration that reduced para-
site growth by 50 % (IC50). 
 
Cytotoxic assay 
Cytotoxic assay was performed using the 
modified method as previously described 
(Tengchaisri et al., 1998). In brief, cell lines 
suspended in RPMI-1640 containing 10 % 
FBS were seeded at 1 × 104 cells (100 µL) 
per well in 96-well plate and incubated in 
humidified atmosphere, 95 % air, 5 % CO2 
at 37 °C. After 24 h, additional medium 
(100 µL) containing the tested compound 
and vehicle was added to a final concentra-
tion of 50 µg/mL, 0.2 % DMSO, and further 
incubated for 3 days. Cells were subse-
quently fixed with 95 % EtOH, stained with 
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crystal violet solution, and lysed with a solu-
tion of 0.1 N HCl in MeOH, after which ab-
sorbance was measured at 550 nm. Whereas 
HuCCA-1 cell was stained by MTT. IC50 
values were calculated as the drug and sam-
ple concentrations at 50 % inhibition of the 
cell growth. 
 
RESULTS AND DISCUSSIONS 
 
Isolation 
D. rubra stem solvent extracts (hexane, 
dichloromethane, ethyl acetate and metha-
nol) were tested for antimicrobial, antima-
larial and cytotoxic activities. Two active 
antimalarial extracts (dichloromethane and 
ethyl acetate) were isolated by repeated sil-
ica gel column chromatography. The di-
chloromethane extract gave lupeol (1, 826.4 
mg) from fractions D2.3 and D3. Lupenone 
(2, 12.2 mg) was isolated from fraction 
D2.2. Fraction D4 afforded betulin (3, 39.1 
mg from D4.3.3.2) and lupeol (74.3 mg 
from D4.1) together with a mixture of β-
sitosterol and stigmasterol (from D4.2.1 and 
D4.3.1). The ethyl acetate extract provided 
lupeol acetate (4, 50.9 mg from fraction 
E1.2), 28-O-acetylbetulin (5, 81.4 mg from 
fraction E4.3) and β-sitosteryl-3-O-β-D-
glucopyranoside (6, 5.1 mg from fraction 
E7). Lupeol was also isolated from fractions 
E2 and E3 (133.9 mg). Fraction E6.3 also 
afforded betulin (22.6 mg). The major con-
stituent, however, is lupeol, with a total 
amount of 1,034.6 mg. Structures of the iso-
lates 1-6 (Figure 1) were deduced by com-
parison of their IR, 1H- and 13C-NMR with 
the literature data. 2D-NMR; COSY, 
HMQC, HMBC, DEPT 90 and DEPT 135 
studies were also performed. Our results 
represent the first report of isolation of con-
stituents 1-6 from D. rubra. These com-
pounds have been found in other Diospyros 
species, e.g., D. maritima Blume (Higa et 
al., 1998; Mallavadhani et al., 1998) and D. 
rhodocalyx (Sutthivaiyakit et al., 1995) and 
other species. Lupeol (1), lupeol acetate (4) 
and glycoside 6 were previously isolated 
from the root of Minusops elengi (Misra and 
Mitra, 1968), lupenone (2) from the stem 
bark of Salacia beddomei (Hisham et al., 
1995), betulin (3) from the leaves of Salacia 
cordata (Tinto et al., 1992). In addition, β-
sitosteryl glycoside 6 was also found in the 
leaves of Enkiathus cernuss (Sakakibara et 
al., 1983). 
 
 
 
Figure 1: Chemical structures of compounds 1-6 
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Bioactivities 
Extracts (hexane, dichloromethane, 
ethyl acetate and methanol) and fractions 
of D. rubra were screened for antimicro-
bial (against 27 strains of microorganisms), 
antimalarial (P. falciparum) and cytotoxic 
(HuCCA-1 and KB cell lines) activities. 
They all were inactive antimicrobials at 
256 µg/mL (Table 1), fair to good antima-
larials (Table 2) and inactive cytotoxic 
agents (Table 3) that exhibited ED50 > 100 
µg/mL. However, selected semi-purified 
fractions (D2, D3, D4 and D5) of the di-
chloromethane extract did not show anti-
malarial activity. This is presumably due to 
some synergistic effects of the compounds 
in the dichloromethane extract. Interest-
ingly, semi-purified fractions of the di-
chloromethane and ethyl acetate extracts 
exerted antimicrobial activity with mini-
mum inhibitory concentrations (MICs) in 
the 64–256 µg/mL range. In particular, the 
active fractions (D4.4, D4.5, E6, E6.2, 
E6.4 and E7) all selectively inhibited the 
growth of Corynebacterium diphtheriae 
NCTC 10356; D4.4 and E6.2 were the 
most active fractions with MIC of 
64 µg/mL. 
Additionally, Bacillus subtilis ATCC 
6633 and Bacillus cereus, as well as Mi-
crococcus lutens ATCC 10240, were also 
inhibited by E6 and E7, respectively. The 
isolated compounds; lupeol (1), lupeol ace-
tate (4) and betulin (3) were evaluated for 
antimicrobial action. It was shown (Table 
1) that 3 exhibited the activity against 
Streptococcus pyogenes, with a MIC of 85 
µg/mL, but the compounds 1 and 4 were 
inactive toward all the tested organisms at 
256 µg/mL. Betulin was previously re-
ported to be active against Fusarium ox-
ysporum (Cota et al., 2003), but no signifi-
cant antimicrobial activity of betulin was 
observed against Streptococcus pneumo-
niae R6 and Staphylococcus aureus 
OM481 and OM 584 (MICs >128 µg/mL) 
(Horiuchi et al., 2007). Betulin also dis-
played anticancer activity against Walker 
carcinoma-256 (Mallavadhani et al., 1998) 
as well as antiviral activity against herpes 
simplex virus (Pavlova et al., 2003) and 
antiinflammatory activity (Mallavadhani et 
al., 1998; Recio et al., 1995). An acetate of 
3, 28-O-acetylbetulin (5), was reported to 
show cytotoxic effects on many tumor cell 
lines (Kvasnica et al., 2005). The cytotoxic 
effects of lupeol (1) and its acetate 4 were 
tested against the HuCCA-1 and KB cell 
lines. Results (Table 3) showed that both 
triterpenoids were inactive (ED50 > 100 
µg/mL). Lupeol was reported to show anti-
cancer activity against Walker carcinoma-
256 (Mallavadhani et al., 1998) and anti-
arthritic action (Argay et al., 1997). Re-
cently, lupeol and lupenone have been re-
ported to inhibit protein tyrosine phos-
phatase 1B (PTP 1B) which appears to be 
an attractive target of new drugs develop-
ment for type 2 diabetes and obesity (Na et 
al., 2009). Lupeol acetate was documented 
to exert antiarthitic and antiurolithiatic ac-
tivities (Argay et al., 1997) including inhi-
bition against stress induced ulcers in rat 
(Mallavadhani et al., 1998). In addition, 
stigmasterol and β-sitosteryl glucoside are 
strong antioxidants (Prachayasittikul et al., 
2008b; Prachayasittikul et al., 2009).  
 
CONCLUSION 
 
The investigation of D. rubra extracts 
with good antimalarial action reveals the 
presence of some bioactive triterpenes in 
this species for the first time. They were 
lupeol (1), lupenone (2), betulin (3), lupeol 
acetate (4), 28-O-acetylbetulin (5), β-
sitosteryl-3-O-β-D-glucopyranoside (6) 
and a mixture of β-sitosterol and stigma-
sterol. These isolates 1–5 are lupane type 
triterpenes which were reported to possess 
antimicrobial, antiviral, anticancer, and 
antiinflammatory activities, as well as in-
hibitory effects on PTP 1B. However, the 
isolated betulin 3 from D. rubra is shown 
to be an active antimicrobial agent. In ad-
dition, the D. rubra extracts (dichloro-
methane and ethyl acetate) exhibited good 
antimalarial activity. The most active frac-
tions from such extracts selectively inhibit 
the growth of C. diphtheriae NCTC 10356 
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with MIC of 64 µg/mL. The results pro-
vide experimental data to support the use 
of D. rubra for medicinal applications. 
 
 
Table 1: Antimicrobial activity* of D. rubra 
Compounda,b,d,e Microorganism MICf (µg/mL) 
D4.4 Corynebacterium diphtheriae NCTC 10356 64 
D4.5 Corynebacterium diphtheriae NCTC 10356 256 
E6c Corynebacterium diphtheriae NCTC 10356 128 
 Bacillus cereus 128 
 Bacillus subtilis ATCC 6633 256 
E6.2c Corynebacterium diphtheriae NCTC 10356 64 
E6.4 Corynebacterium diphtheriae NCTC 10356 256 
E7c Corynebacterium diphtheriae NCTC 10356 128 
 Micrococcus lutens ATCC 10240 256 
Betulin (3) Streptococcus pyogenes 85 
*Ampicillin at 10 µg/mL was used as a control of the testing system; it showed 100 % in-
hibition against Staphylococcus aureus ATCC 25923, Staphylococcus epidermidis ATCC 
12228, B. subtilis ATCC 6633, Neisseria mucosa, Branhamella catarrhalis, Edwardsiella 
tarda and S. pyogenes. Partial inhibition: a against C. diphtheriae NCTC 10356, 50 % (D5 
at 128 µg/mL) and 25 % (E1, E4 and E5 at 256 µg/mL), b against N. mucosa (50 %, E4.4 
at 128 µg/mL), c against M. lutens ATCC 10240 (75 %, E6 and E7 at 128 µg/mL; E6.2 at 
256 µg/mL), d against B. subtilis ATCC 6633 and B. cereus at 128 µg/mL (25 %, D4.4, 
D4.5 and E7). e Fractions D4.2, E1.2, extracts (hexane, CH2Cl2, EtOAc, MeOH) and iso-
lates; lupeol (1) and lupeol acetate (4) were tested at 256 µg/mL, but found to be inactive. 
f MIC is a minimum inhibitory concentration.  
 
Table 2: Antimalarial activity of D. rubra 
Compounda Activity IC50 (µg/mL)b 
Hexane extract Fair 176.20 
Dichloromethane extract Good 23.94 
Ethyl acetate extract Good 33.58 
Methanol extract Fair 135.05 
D2 Inactive 45.05 
D3 Inactive 215.26 
D4 Inactive 473.50 
D5 Inactive 413.95 
a Chloroquine hydrochloride was used as a reference drug; b IC50: for the ex-
tract, 100–1,000 µg/mL denotes fair activity and 10 – <100 µg/mL for good 
activity; for partial purified fractions, >1 µg/mL for inactive antimalarials. 
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Table 3: Cytotoxic activity of D. rubra 
ED50 (µg/mL)a,b Compound 
HuCCA-1 KB 
Hexane extract >182 >182 
Dichloromethane extract   163   163 
Ethyl acetate extract >144 >144 
Methanol extract >173 >173 
Lupeol (1) >100 >100 
Lupeol acetate (4) >100 >100 
Etoposide   4.0   0.25 
aED50 > 100 µg/mL denotes inactive cytotoxic activity; b The assays were performed in 
triplicate, using etoposide as a reference drug. 
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